Role of the tumor microenvironment in the activity and expression of the p-glycoprotein in human colon carcinoma cells

Oncology Reports

Volumn 17, Issue 1, 2007, Pages 239-244

  Lotz, Christopher ^a   Kelleher, Debra K ^a   Gassner, Birgit ^b   Gekle, Michael ^b   Vaupel, Peter ^a   Thews, Oliver ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Acidosis; Drug efflux; Hypoxia; Intracellular pH; p glycoprotein

Indexed keywords

DAUNORUBICIN; GLYCOPROTEIN P;

ACIDOSIS; ARTICLE; BIOSYNTHESIS; CELL HYPOXIA; COLORECTAL TUMOR; HUMAN; METABOLISM; PH; PHYSIOLOGY; TUMOR CELL LINE;

ACIDOSIS; CELL HYPOXIA; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DAUNORUBICIN; HUMANS; HYDROGEN-ION CONCENTRATION; P-GLYCOPROTEIN;

EID: 39049188220     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.1.239     Document Type: Article

References (31)

1. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE and Gottesman MM: P-glycoprotein: from genomics to mechanism. Oncogene 22: 7468-7485, 2003. (Pubitemid 37487170)
2. Schinkel AH and Jonker JW: Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55: 3-29, 2003. (Pubitemid 36078452)
3. Leonard GD, Fojo T and Bates SE: The role of ABC transporters in clinical practice. Oncologist 8: 411-424, 2003. (Pubitemid 37238869)
4. Fojo T and Bates S: Strategies for reversing drug resistance. Oncogene 22: 7512-7523, 2003. (Pubitemid 37487173)
5. Siegsmund MJ, Kreukler C, Steidler A, Nebe T, Kohrmann KU and Alken P: Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein. Urol Res 25: 35-41, 1997. (Pubitemid 27141802)
6. Konerding MA, Malkusch W, Klapthor B, van Ackern C, Fait E, Hill SA, Parkins C, Chaplin DJ, Presta M and Denekamp J: Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts. Br J Cancer 80: 724-732, 1999. (Pubitemid 29209835)
7. Vaupel P, Kallinowski F and Okunieff P: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors (Review). Cancer Res 49: 6449-6465, 1989. (Pubitemid 20008770)
8. Höckel M and Vaupel P: Tumor hypoxia: definitions and current clinical, biological, and molecular aspects. J Natl Cancer Inst 93: 266-276, 2001. (Pubitemid 32219813)
9. Kunikane H, Zalupski MM, Ramachandran C, KuKuruga MA, Lucas D, Ryan JR and Krishan A: Flow cytometric analysis of p-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas. Cytometry 30: 197-203, 1997.
10. Versteeg HH, Nijhuis E, van den Brink GR, Evertzen M, Pynaert GN, van Deventer SJ, Coffer PJ and Peppelenbosch MP: A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. Biochem J 350: 717-722, 2000.
11. Weiner ID and Hamm LL: Use of fluorescent dye BCECF to measure intracellular pH in cortical collecting tubule. Am J Physiol 256: F957-F964, 1989.
12. Vaupel P, Schaefer C and Okunieff P: Intracellular acidosis in murine fibrosarcomas coincides with ATP depletion, hypoxia, and high levels of lactate and total Pi. NMR Biomed 7: 128-136, 1994. (Pubitemid 2088962)
13. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, Keating MJ and Huang P: Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65: 613-621, 2005.
14. Liang BC: Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines. J Neurooncol 29: 149-155, 1996.
15. Sakata K, Kwok TT, Murphy BJ, Laderoute KR, Gordon GR and Sutherland RM: Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. Br J Cancer 64: 809-814, 1991.
16. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC and Colgan SP: Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62: 3387-3394, 2002. (Pubitemid 34651384)
17. Thews O, Gassner B, Kelleher DK, Schwerdt G and Gekle M: Impact of extracellular acidity on the activity of p-glycoprotein and the cytotoxicity of chemotherapeutic drugs. Neoplasia 8: 143-152, 2006.
18. Ferrao P, Sincock P, Cole S and Ashman L: Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia. Leuk Res 25: 395-405, 2001. (Pubitemid 32294284)
19. Kim H, Barroso M, Samanta R, Greenberger L and Sztul E: Experimentally induced changes in the endocytic traffic of P-glycoprotein alter drug resistance of cancer cells. Am J Physiol 273: C687-C702, 1997.
20. Felix RA and Barrand MA: P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress. J Neurochem 80: 64-72, 2002. (Pubitemid 34614578)
21. Ledoux S, Yang R, Friedlander G and Laouari D: Glucose depletion enhances P-glycoprotein expression in hepatoma cells: role of endoplasmic reticulum stress response. Cancer Res 63: 7284-7290, 2003. (Pubitemid 37413469)
22. Lee G and Piquette-Miller M: Cytokines alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays. J Pharm Sci 92: 2152-2163, 2003. (Pubitemid 37356689)
23. Wartenberg M, Fischer K, Hescheler J and Sauer H: Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids. Int J Cancer 85: 267-274, 2000. (Pubitemid 30023078)
24. Wartenberg M, Gronczynska S, Bekhite MM, Saric T, Niedermeier W, Hescheler J and Sauer H: Regulation of the multidrug resistance transporter P-glycoprotein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species. Int J Cancer 113: 229-240, 2005. (Pubitemid 39628313)
25. Fine RL, Chambers TC and Sachs CW: P-glycoprotein, multidrug resistance and protein kinase C. Oncologist 1: 261-268, 1996. (Pubitemid 126669387)
26. Chambers TC, Pohl J, Raynor RL and Kuo JF: Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J Biol Chem 268: 4592-4595, 1993. (Pubitemid 23081564)
27. Tsuruoka S, Sugimoto K, Fujimura A, Imai M, Asano Y and Muto S: Protein kinase C and phosphatidylinositol 3-kinase independently contribute to P-glycoprotein-mediated drug secretion in the mouse proximal tubule. Pflugers Arch 442: 321-328, 2001. (Pubitemid 32591972)
28. + exchange subtype 1 inhibition during extracellular acidification and hypoxia in glioma cells. J Neurochem 80: 36-44, 2002.
29. Wahl ML, Owen JA, Burd R, Herlands RA, Nogami SS, Rodeck U, Berd D, Leeper DB and Owen CS: Regulation of intracellular pH in human melanoma: potential therapeutic implications. Mol Cancer Ther 1: 617-628, 2002.
30. Chen JS, Agarwal N and Mehta K: Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools. Breast Cancer Res Treat 71: 237-247, 2002. (Pubitemid 34263987)
31. 549 cells. Biosci Rep 20: 129-138, 2000.